Lcnb Corp Gilead Sciences, Inc. Transaction History

Lcnb Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 11, 2020	SELL	$62.63 - $80.22 $206,303 - $264,244	-3,294 Closed	0 $0
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $1,848 - $2,033	-30 Reduced 0.9%	3,294 $214,000
Q3 2019 Nov 08, 2019	SELL	$62.51 - $69.0 $27,629 - $30,498	-442 Reduced 11.74%	3,324 $211,000
Q2 2019 Aug 01, 2019	SELL	$61.87 - $69.38 $6,187 - $6,938	-100 Reduced 2.59%	3,766 $254,000
Q1 2019 May 02, 2019	SELL	$62.53 - $70.05 $4,377 - $4,903	-70 Reduced 1.78%	3,866 $251,000
Q4 2018 Feb 19, 2019	SELL	$60.54 - $79.0 $10,594 - $13,825	-175 Reduced 4.26%	3,936 $246,000
Q3 2018 Nov 09, 2018	SELL	$71.28 - $78.92 $19,245 - $21,308	-270 Reduced 6.16%	4,111 $317,000
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $284,239 - $331,554	4,381 New	4,381 $310,000

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Lcnb Corp, based on Form 13F filings with the SEC.

Stay updated on Lcnb Corp with notifications on news.